Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
CNBC -

Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are progressing on their own treatments.

Related Articles

Latest in News

More from CNBC | Robert Bradway Breaking news Zealand Pharma A S AstraZeneca PLC Structure Therapeutics Inc Altimmune Inc Viking Therapeutics Inc Novo Nordisk A Science Eli Lilly and Co Amgen Inc Health care industry Pharmaceuticals Biotech and Pharmaceuticals Biotechnology Business business news cnbc Articles US: News Companies Business News Health & Science source:tagname:CNBC US Source